Synaptogenix, Inc. (SNPX)
USD 2.57
(-5.51%)
USD 2.57
(-5.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.17 Million | -11.21 Million | -8.71 Million | -8.1 Million | -11.88 Million | -7.69 Million |
| Net Income | -6.03 Million | -5.57 Million | -12.61 Million | -12.7 Million | -15.13 Million | -11.02 Million |
| Depreciation & Amortization | 6347.00 | 5714.00 | 4966.00 | 4872.00 | 4385.00 | 2999.00 |
| Deferred income taxes | 215.57 Thousand | - | 560.03 Thousand | 2.08 Million | 1.07 Million | - |
| Stock-based compensation | 1 Million | 3.74 Million | 3.28 Million | 1.7 Million | 4.18 Million | - |
| Change in working capital | 358.02 Thousand | -614.94 Thousand | 25.93 Thousand | 693.81 Thousand | -2.36 Million | 1.1 Million |
| Other non-cash items | -723.97 Thousand | -8.77 Million | 27.15 Thousand | 120 Thousand | 352.74 Thousand | 564.05 Thousand |
| Investing Cash Flow | -2 Million | -7414.00 | -3199.00 | -5413.00 | -5214.00 | -3186.00 |
| Investments in PPE | -2707.00 | -7414.00 | -3199.00 | -5413.00 | -5214.00 | -3186.00 |
| Acquisitions | -562.4 Thousand | - | - | - | - | - |
| Investment purchases | -2 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 562.4 Thousand | - | - | - | - | - |
| Financing Cash Flow | -1.64 Million | 14.48 Million | 37.13 Million | -3.47 Million | 419.84 Thousand | 20.44 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -641.06 Thousand | -115.89 Thousand | - | -20 Million | - | - |
| Common Stock Repurchased | -1 Million | - | - | - | - | - |
| Common Stock Issuance | 118 Thousand | 359.35 Thousand | 37.13 Million | 120 Thousand | 419.84 Thousand | 20.44 Million |
| Other Financing Activities | -1000.00 | 14.23 Million | -1529.00 | 16.4 Million | 419.84 Thousand | - |
| Accounts receivables | - | - | - | -127.44 Thousand | - | - |
| Accounts payables | -215.57 Thousand | -636.3 Thousand | 36.17 Thousand | 847.25 Thousand | -2.48 Million | 1.65 Million |
| Inventory | - | - | - | 127.44 Thousand | - | - |
| Other working capital | 573.59 Thousand | 21.35 Thousand | -10.24 Thousand | -153.44 Thousand | 116.69 Thousand | -552.64 Thousand |
| Cash at beginning of period | 37.47 Million | 34.21 Million | 5.79 Million | 17.38 Million | 28.85 Million | 16.11 Million |
| Cash at end of period | 28.66 Million | 37.47 Million | 34.21 Million | 5.79 Million | 17.38 Million | 28.85 Million |
| Capital Expenditure | -2707.00 | -7414.00 | -3199.00 | -5413.00 | -5214.00 | -3186.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.81 Million | 3.26 Million | 28.41 Million | -11.58 Million | -11.47 Million | 12.74 Million |
| Free Cash Flow | -5.17 Million | -11.21 Million | -8.71 Million | -8.1 Million | -11.89 Million | -7.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.27 Million | -206.69 Thousand | -6.03 Million | -995.96 Thousand | 763.2 Thousand | -4.09 Million |
| Depreciation & Amortization | 1317.00 | 1399.00 | 6347.00 | 1210.00 | 1723.00 | 1724.00 |
| Deferred income taxes | - | - | 215.57 Thousand | 212.93 Thousand | -1.64 Million | 2.69 Million |
| Stock-based compensation | 3420.00 | 14.4 Thousand | 1 Million | 15.06 Thousand | 15.06 Thousand | 334.41 Thousand |
| Change in working capital | 387.68 Thousand | -723.74 Thousand | 358.02 Thousand | 770.19 Thousand | -313.4 Thousand | -177.57 Thousand |
| Other non-cash items | -203.02 Thousand | -693.96 Thousand | -723.97 Thousand | -1.06 Million | 4500.00 | 4500.00 |
| Investing Cash Flow | -500 Thousand | -500 Thousand | -2 Million | -2 Million | - | -669.00 |
| Investments in PPE | - | - | -2707.00 | - | - | -669.00 |
| Acquisitions | - | - | -562.4 Thousand | - | - | - |
| Investment purchases | -500 Thousand | -500 Thousand | -2 Million | -2 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -500 Thousand | -500 Thousand | 562.4 Thousand | -2000.00 | - | - |
| Financing Cash Flow | - | - | -1.64 Million | -51.00 | 49.00 | -1.64 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -2.61 Million | -641.06 Thousand | -51.00 | -49.00 | -641.06 Thousand |
| Common Stock Repurchased | - | - | -1 Million | 1 Million | - | -1 Million |
| Common Stock Issuance | - | 104.5 Thousand | 118 Thousand | 13.5 Thousand | - | - |
| Other Financing Activities | - | - | -1000.00 | -210.96 Thousand | - | -1 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 236.42 Thousand | -205.72 Thousand | -215.57 Thousand | 230.41 Thousand | -224.92 Thousand | 83.24 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 151.26 Thousand | -518.02 Thousand | 573.59 Thousand | 539.78 Thousand | -88.47 Thousand | -260.81 Thousand |
| Cash at beginning of period | 26.32 Million | 28.66 Million | 37.47 Million | 31.72 Million | 32.89 Million | 35.78 Million |
| Cash at end of period | 24.97 Million | 26.32 Million | 28.66 Million | 28.66 Million | 31.72 Million | 32.89 Million |
| Capital Expenditure | - | - | -2707.00 | - | - | -669.00 |
| Effect of forex changes on cash | - | - | - | -161.57 Thousand | - | - |
| Net cash flow / Change in cash | -1.35 Million | -2.33 Million | -8.81 Million | -3.06 Million | -1.17 Million | -2.88 Million |
| Free Cash Flow | -853.53 Thousand | -1.83 Million | -5.17 Million | -1.06 Million | -1.17 Million | -1.24 Million |
SNV
0856
A1G
600070
3856
AASTAFIN